Showing results (631-640 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|February 26, 2015
Genetic variations in NADPH-CYP450 oxidoreductase in a Czech Slavic cohortMária Tomková, Satya Prakash Panda, Ondřej Šeda, et al.
Pharmacogenomics|February 26, 2015
Donor IL-18 rs5744247 polymorphism as a new biomarker of tacrolimus elimination in Chinese liver transplant patients during the early post-transplantation period: results from two cohort studiesJunwei Fan, Xiaoqing Zhang, Lei Ren, et al.
Pharmacogenomics|February 26, 2015
In vitro human cell line models to predict clinical response to anticancer drugsNifang Niu, Liewei Wang
Pharmacogenomics|February 26, 2015
Pharmacogenomics toward personalized tamoxifen therapy for breast cancerHitoshi Zembutsu
Pharmacogenomics|April 1, 2015
FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritisCristina Lucía Dávila-Fajardo, Tahar van der Straaten, Rene Baak-Pablo, et al.
Pharmacogenomics|April 1, 2015
Mechanistic insights into the effect of CYP2C9*2 and CYP2C9*3 variants on the 7-hydroxylation of warfarinAddepalli Pavani, Shaik Mohammad Naushad, Balraj Alex Stanley, et al.
Pharmacogenomics|January 24, 2015
P-glycoprotein: a clue to vitamin K antagonist stabilizationLiliane Gschwind, Victoria Rollason, Françoise Boehlen, et al.
Pharmacogenomics|January 24, 2015
Pharmacogenetics of chemotherapy-induced nausea and vomitingShigekazu Sugino, Piotr K Janicki
Pharmacogenomics|July 4, 2020
High levels of tumor-infiltrating lymphocytes showed better clinical outcomes in FOLFOX-treated gastric cancer patientsWei Li, Weili Wang, Ping Liao, et al.
Pharmacogenomics|June 30, 2020
Poly-(ADP-ribose) polymerase inhibitors: paradigm shift in the first-line treatment of newly diagnosed advanced ovarian cancerFady Gh Haddad, Elias Karam, Elissar Moujaess, et al.
Pageof 276